default author photo

Nimita Fifadara

Government of the United States of America - Centers for Disease Control and Prevention (CDC)

SCHOLARLY PAPERS

1

DOWNLOADS

57

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety Monitoring of Bivalent Mrna Covid-19 Vaccine Among Pregnant Persons in the Vaccine Adverse Event Reporting System – United States, September 1, 2022 – March 31, 2023

Number of pages: 21 Posted: 10 Oct 2023
Pedro L. Moro, Grace Carlock, Nimita Fifadara, Tei Habenicht, Bicheng Zhang, Penelope Strid and Paige L. Marquez
Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC) and Government of the United States of America - Centers for Disease Control and Prevention (CDC)
Downloads 57 (1,000,027)
Citation 1

Abstract:

Loading...

adverse events, Epidemiology, Coronavirus, COVID-19, mRNA COVID-19 vaccines, bivalent mRNA COVID-19 vaccine, BA.4/BA.5 strains, SARS-CoV-2, pregnancy, surveillance, Vaccine safety